Antibody Technologies Market Research Reports & Industry Analysis
Antibody technologies involve the use of specialized proteins called antibodies to target and detect specific molecules, often used in medical diagnostics, therapeutics, and research. This field is evolving quickly due to scientific advancements and the growing demand for personalized treatments. To help you stay updated on the latest developments, MarketResearch.com offers a comprehensive collection of reports on antibody technologies.
Valuable Antibody Technologies Research and Analysis
- Find detailed data on various market segments including precision medicine, biosimilars, biologics, protein engineering, and more.
- Obtain antibody technologies market sizing and growth projections, discussions of key drivers and challenges, pricing and regulatory analysis, and company profiles.
- Read expert commentary on recent technological innovations and industry trends to gain a clear understanding of emerging opportunities.
Your Research Partner
Whether you're an experienced industry professional, a consultant, or a busy executive, our antibody technologies market research reports are designed to help you make informed decisions. With reliable data and thorough analyses, these reports support your decision-making process. By choosing MarketResearch.com, you can gain the intelligence needed to stay competitive and take advantage of new opportunities.
Antibody Technologies Industry Research & Market Reports
-
South and Central America Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... & antibody-like proteins, and Biosimilar antibody products) The South and Central America (SCAM) next-generation antibody market are expected to reach US$ 695.60 million by 2028 from US$ 333.92 million in 2021. It is estimated to ... Read More
-
2022 Global Forecast for Research Antibodies (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Biologics Market Covering Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines; Global Summary 2021: Covid 19 Impact and Recovery
... of 8.65%. The global biologics market is expected to grow from $253.4 billion in 2020 to $420.57 billion in 2025 at a CAGR of 10.66%. Biologics Market Covering Monoclonal Antibodies (MAbS); Therapeutic Proteins; Vaccines; Global ... Read More
-
U.S. Sterile Injectables Market, by Molecule Type (Large Molecule and Small Molecule), by Drug Type (Monoclonal Antibody (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulin’s, Blood Factors, Peptide Antibiotics, and Others), by Therapeutic Application (Cancer, Metabolic Diseases, Cardiovascular Diseases, Central Nervous System Disorder, Infectious Diseases, Musculoskeletal Disorders, and Others), by Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Diseases, Cardiovascular Diseases, Central Nervous System Disorder, Infectious Diseases, Musculoskeletal Disorders, and Others), by Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online ... Read More
-
Antibody Therapy Market
... important market dynamics. After conducting thorough research on the historical and current growth parameters of the Antibody Therapy Market, the growth prospects of the market are obtained with maximum precision. Market Segmentation The Antibody Therapy ... Read More
-
Immunohistochemistry (IHC) Market Size, Share & Trends Analysis By Product, By Application, By End-Users, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
... 2030 According to SPER Market Research, the Immunohistochemistry Market is estimated to reach USD 5.8 billion by 2030 with a CAGR of 6.5%. Increase in geriatric population, prevalence of infectious disease, advanced technology, increase in ... Read More
-
Middle East and Asia Pacific Antibody Drugs Market, by Type (Monoclonal Antibodies, Polyclonal Antibody, Bispecific Antibody, Biosimilars, Single Domain Antibody, CAR-T, and Anti-idiotype Antibody), by Disease Indication (Oncology, Neurology, Autoimmune Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (Middle East (Kingdom of Saudi Arabia, UAE, Israel, Iran, Jordan, Turkey, Qatar, and Rest of Middle East) and Asia Pacific (South East Asia, The Philippines, Malaysia, Singapore, Thailand, Vietnam, Rest of South East Asia, Taiwan, Hong Kong, Macau, Japan, South Korea, India, Australia, China, and Rest of Asia Pacific)) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (Middle East (Kingdom of Saudi Arabia, UAE, Israel, Iran, Jordan, Turkey, Qatar, and Rest of Middle East) and Asia Pacific (South East Asia, The ... Read More
-
Single-use Bioprocessing Market By Product (Bioreactors, Tangential-Flow Filtration Devices, Depth Filters, Disposable Filter Cartridges, Media Bags And Containers, Mixing Systems, Tubing Assemblies, Sampling Systems, Others), By Application (Monoclonal Antibody Production, Vaccine Production, Plant Cell Cultivation, Patient Specific Cell Therapies, Others), By Method (Filtration, Storage, Cell Culture, Mixing, Purification), By End User (Biopharmaceutical Manufacturers, Life Science R&D Companies & Academic Research, Contract Research Organization & Manufacturers): Global Opportunity Analysis and Industry Forecast, 2020-2030
... Patient Specific Cell Therapies, Others), By Method (Filtration, Storage, Cell Culture, Mixing, Purification), By End User (Biopharmaceutical Manufacturers, Life Science R&D Companies & Academic Research, Contract Research Organization & Manufacturers): Global Opportunity Analysis and Industry ... Read More
-
Antibody Discovery Services and Platforms Market (4th Edition), 2021-2035
... pharmacological interventions have evolved into a prominent class of therapeutics. These therapeutics have high target specificities and favorable safety profiles. Currently, close to 100 monoclonal antibodies have been approved while more than 500 molecules are ... Read More
-
Antibody Cocktails Market, by Type (Monovalent Antibody and Polyvalent Antibody), by Indication (COVID-19, Cancer, HIV, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 An antibody, also called immunoglobulin, is a protective protein produced by the immune system of the body in response ... Read More
-
Hematological Malignancies Emerging Therapeutics Market - A Global and Regional Analysis: Focus on Therapeutic Type (Marketed), Potential Pipeline Products, Indication, and Region - Analysis and Forecast, 2021-2031
... Market Segmentation Marketed Drugs - Monoclonal Antibodies and CAR-T Cell Therapy Potential Pipeline Products - Monoclonal Antibodies and CAR-T Cell Therapy Indication - Leukemia, Lymphoma, and Multiple Myeloma Regional Segmentation North America - U.S. and ... Read More
-
Chronic Liver Diseases Therapeutics Market, by Treatment Type (Antiviral Drugs, Immunosuppressant’s, Vaccines, Immunoglobulin’s, Corticosteroids, Targeted Therapy, and Chemotherapy), by Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The liver ... Read More
-
Blood Plasma Derivatives Market by Product Type (Albumin, Anti-inhibitor Coagulation Factor, Factor VIII, Factor IX Concentrate, Immunoglobulins, Rh Immunoglobulin, Alpha 1-Protaese Inhibitor, and Anti–Thrombin), Application (HIV, Hemophilia A, Hemophilia B, Hepatitis C, Bleeding Disorders, Genetic Lung Disorders, Immune Deficiency System, Liver Conditions, and Viral Disease), and End User (Hospital, Clinic, Transfusion Center, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030
... Lung Disorders, Immune Deficiency System, Liver Conditions, and Viral Disease), and End User (Hospital, Clinic, Transfusion Center, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030 The global blood plasma derivatives market was valued at ... Read More
-
Middle East and Asia Pacific Biotechnology Market, by Technology (Nanobiotechnology, Tissue Engineering and Regeneration, Fermentation, Cell Based Assay, CRISPR, and Others ), by Application (Molecular Biology, Gene Synthesis, Gene Editing, Mammalian Protein Expression, Recombinant Antibody Expression, Peptide Synthesis, Protein Expression, Monoclonal and Polyclonal Antibody Generation, and Others), by End User (Biotechnology & Pharmaceutical Companies, Research Institutes & Laboratories, Academic Institutions, and Others), and by Region (Asia Pacific and Middle East) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Expression, Peptide Synthesis, Protein Expression, Monoclonal and Polyclonal Antibody Generation, and Others), by End User (Biotechnology & Pharmaceutical Companies, Research Institutes & Laboratories, Academic Institutions, and Others), and by Region (Asia Pacific and Middle East) ... Read More
-
2022 Global Forecast for Neuroscience Antibodies & Assays (2023-2028 Outlook)-High Tech & Emerging Markets Report
... countries. The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales ... Read More
-
Plasma Derived Medicine Market, by Product Type (Albumin, Coagulation factors, Immunoglobulins, and Others), by Indication (Pelvic Inflammatory Disease (PID), Bleeding Disorders, Alpha-1 Antitrypsin Deficiency (AATD), Hereditary Angioedema (HAE), Chronic Inflammatory Demyelinating Polyneuropathy, Guillain-Barre Syndrome, Multifocal Motor Neuropathy, Liver Diseases, Primary Immune Thrombocytopenia, Infections, and Other Orphan Diseases), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Motor Neuropathy, Liver Diseases, Primary Immune Thrombocytopenia, Infections, and Other Orphan Diseases), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and ... Read More
-
2022 Global: Custom Antibody - Innovative Markets Forecast (2028) report
... 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression analysis in ... Read More
-
2022 Global Forecast for Immunoprecipitation (2023-2028 Outlook)-High Tech & Emerging Markets Report
... market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments value) ... Read More
-
2022 Global Forecast for Immunofluorescence Assay (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
2022 Global: Cell Signaling - Innovative Markets Forecast (2028) report
... 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression analysis in ... Read More
-
2022 Global Forecast for Immunotherapy Drugs (2023-2028 Outlook)-High Tech & Emerging Markets Report
... global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product shipments ... Read More
-
Blood Grouping Reagents Market Research Report: Information by Product (Consumables and Instruments), by Technique (PCR-based and Microarray Techniques, Assay-Based Techniques, Massively Parallel Sequencing Techniques, Serology), by Test Type (Blood Group and Phenotypes, Antibody Screening, Crossmatching Tests, Antibody Identification, Coombs’s Test, and Antigen Typing), by End User (Hospitals, Blood Banks, Clinical Laboratories) and Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2027
... Tests, Antibody Identification, Coombs’s Test, and Antigen Typing), by End User (Hospitals, Blood Banks, Clinical Laboratories) and Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2027 Blood Grouping Reagents Market ... Read More
-
Convalescent Plasma Therapy Global Market Report 2022 Including: 1) By Application: Prophylaxis; Treatment 2) By End-Users: Hospitals & Clinics; Laboratories & Research Institutes 3) By Antibody type: IgM; IgG; IgA Covering: Bio Farma; Grifols; Hilton Pharma; Biotest; BPL; LFB; Octapharma; CSL Behring; Takeda Pharmaceutical Company Limited; Orthosera Kft.
... focuses on convalescent plasma therapy market which is experiencing strong growth. The report gives a guide to the convalescent plasma therapy market which will be shaping and changing our lives over the next ten years ... Read More
-
Middle East and Turkey Chronic Liver Disease (CLD) Therapeutics Market, by Disease Type (Hepatitis, Alcohol Induced Liver Disease, Liver Cancer, Fatty Liver Disease, and Others), by Drug Class (Chemotherapy Drugs, Targeted therapy, Vaccines, Immunoglobulin, and Others), by Route of Administration (Oral and Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Country (Turkey, Saudi Arabia, Israel, UAE, Egypt, and Rest of Middle East and Turkey) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Others), by Route of Administration (Oral and Parenteral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Country (Turkey, Saudi Arabia, Israel, UAE, Egypt, and Rest of Middle East and Turkey) - ... Read More
-
Antibody Therapy Market Size By Type (Monoclonal Antibodies [mAbs] {Oncology, Autoimmune Diseases, Infectious Diseases}, Antibody-drug Conjugates [ADCs]), By End-use (Hospitals, Specialty Centers), Industry Analysis Report, Regional Outlook, Growth Potential, COVID-19 Impact Analysis, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Market Share & Forecast, 2022 - 2028 The antibody therapy market is estimated to grow significantly by 2028 owing to the increase in use of monoclonal antibodies (mABs) in COVID-19 patients. Following the onset of ... Read More
Research Assistance
